Remy Durand

Remy Durand is a seasoned professional in the healthcare investment sector, currently serving as Principal at Alpine BioVentures since 2018, and as Chief Business Officer at Alpine Immune Sciences, Inc., where significant contributions include leading business development and corporate strategy during the company's acquisition by Vertex Pharmaceuticals. Prior experience includes a Vice President role at Frazier Healthcare Partners and as a Senior Associate at GE Ventures Healthcare, focusing on portfolio management and investment evaluation. Durand's earlier career encompassed consulting roles in the medical device field and internships with innovation-focused organizations, complemented by a strong academic background with a PhD in Bioengineering from Stanford University and a BSE in Biomedical Engineering from Case Western Reserve University.